Lenvima
NDC 62856-720, Lenvatinib, capsule, from Eisai Inc..
- Product NDC
- 62856-720
- Status
- Listed
- Labeler
- Eisai Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA206947
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62856-720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LENVATINIB10 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Receptor Tyrosine Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62856-720-30 | 62856072030 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-720-30) / 10 CAPSULE in 1 BLISTER PACK (62856-720-05) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f4bedd21-efde-44c6-9d9c-b48b78d7ed1e
Use it
Look up 62856-720 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62856-720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62856-720. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.